4.87M Cosmos Health warrants expire unexercised, preventing dilution and simplifying capital structure
COSM is trading near its 52-week low of $0.246 (1.9% above the low).
Summary
Cosmos Health announced that 4.87 million Series B warrants, representing approximately 38% of its total outstanding warrants, expired unexercised. This prevents the issuance of new shares, thereby avoiding potential dilution for existing shareholders and simplifying the company's capital structure. This development is positive, especially as the company recently reported a going concern warning, widened losses, and increased cash burn in its Q1 2026 10-Q filing, and filed an S-3/A to register 73.5 million shares for resale by noteholders.
At the time of this announcement, COSM was trading at $0.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.8M. The 52-week trading range was $0.25 to $1.32. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.